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T lymphocytes, cytokines, and macrophages play important roles in the clearance of Mycobacterium 
tuberculosis (Mtb) by the immune system. This study aimed to investigate the effects of isoniazid 
on the functions of both innate and adaptive immune cells. Healthy rats were randomly divided into 
experimental and control groups. Each group was randomly divided into three subgroups and named 
according to the duration of drug feeding, 1, 3, and 3 months followed by drug withdrawal for 1 
month. The experimental groups were fed with isoniazid (12 mg/mL) and the control groups with 
normal saline. The percentage of CD4+ and CD8+T lymphocytes, level of interleukin (IL)-12 and 
interferon (IFN)-γ, and function of macrophages were determined at these three time points. Isoniazid 
significantly increased the percentage of CD4+T lymphocytes and the CD4+/CD8+T lymphocyte cell 
ratio (P < 0.05). It transiently (<1 month) enhanced the functions of rat macrophages significantly (P 
< 0.05). In summary, isoniazid could increase the percentage of CD4+T lymphocytes, CD4+/CD8+T 
lymphocyte cell ratio, and enhance macrophage function in healthy rats. 
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INTRODUCTION
Tuberculosis (TB) is an infectious disease caused 
by Mycobacterium tuberculosis (Mtb) bacteria which 
may damage multiple organ systems and poses a 
serious harm to human health. According to the World 
Health Organization’s report on the global tuberculosis 
epidemic, about one-third of the world’s population was 
infected with Mtb in 2015, 10.4 million new TB patients 
were diagnosed, and more than 1.4 million patients 
died of the disease (Sisay et al., 2016). China has a 
high incidence of TB, ranking second in the world. At 
present, due to the increase in human immunodeficiency 
virus/acquired immunodeficiency syndrome, the use 
of immunosuppressive and cytotoxic drugs, and the 
incidence of drug-resistant TB, the severity of TB cases 
has increased (Das, Satapathy, Murmu, 2016; Ebonyi et 
al., 2016; Lima et al., 2017). Therefore, TB has become 
a serious public health problem in China. 
T lymphocytes, cytokines, and macrophages play 
important roles in the clearance of Mtb-related antigens. 
Insufficient number or dysfunction of T lymphocytes 
and macrophages, and the lack of related cytokines may 
lead to decreased immunity to Mtb. Therefore, immune 
status is closely related to the occurrence, development, 
and therapeutic response to TB (Grover et al., 2014; 
Mosquera-Restrepo et al., 2017). In recent years, it has 
been found that some antibacterial drugs not only kill 
pathogens but also regulate immune function during 
treatment (Hamilton-Miller, 2001; Schultz, Speelman, 
van der Poll, 2001; Tauber, Nau, 2008). Some b-lactam 
antibiotics, such as cefodizime, can improve immune 
function (Wang et al., 2015). Although anti-tuberculosis 
drugs have been used for many years, studies on 
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their immune regulation are lacking. Therefore, it is 
important to investigate the effects of anti-tuberculosis 
drugs on immune function, especially those related to 
the clearance of Mtb. 
Isoniazid is one of the most important first-line 
drugs for treating TB. It has strong antibacterial 
effects; thus, it is used throughout the period of 
reinforcement and consolidation. The side effects 
of isoniazid, such as liver damage, may be related 
to the high level of immune response (Usui et al., 
2017; Vinnard et al., 2017). At present, it is not clear 
whether isoniazid has any effect on immune functions 
related to the clearance of Mtb. Therefore, we explored 
the effects of isoniazid on the immune functions in 
healthy rats, and found that isoniazid can serve as a 
potential immune booster. 
MATERIAL AND METHODS
All the experimental animals and procedures were 
approved by the animal experiment ethics committee 
of the Southwest Medical University, China (approval 
number: 201703192).
Animals
Two-month-old male Sprague-Dawley rats of clean 
grade were purchased from Chongqing Tengxin Bio-
Technology Co., Ltd. [Chongqing, China; production 
license: SCXK (Yu) 2012-0008]. All the rats were fed 
under the same standard conditions with a temperature 
of 23 °C ± 3 °C and relative humidity of 50% ± 10%.
Grouping
A total of 60 rats were randomly divided into 
experimental and control groups (30 rats in each group). 
Each group was randomly divided into three subgroups 
(10 rats in each subgroup) and named according to the 
time points of drug feeding 1, 3, and 3 months, followed 
by drug withdrawal for 1 month.
Drug delivery method
Experimental group: Isoniazid tablets (Chengdu 
Jinhua Pharmaceutical Co. Ltd., China) were ground into 
a powder, and the equivalent dose ratio was calculated 
according to human and rat body surface area (rats 
received six times the adult human dosage). Isoniazid 
powder was dissolved in saline at a concentration of 
12 mg/mL (Sichuan Meida Kangjiale Pharmaceutical 
Co. Ltd., Chengdu, China). Rats were administered 
isoniazid solution (1 mL/100 g body weight, once every 
other day) intragastrically.
Control group: The rats were administered normal 
saline (1 mL/100 g body weight, once every other day) 
intragastrically. Feeding conditions were the same as 
those in the experimental group.
Sample collection 
The rats were anesthetized with 3% pentobarbital 
sodium solution (30 mg/kg). Next, 2 mL blood samples 
were obtained from the hearts. Anticoagulated whole 
blood (300 μL) was used to determine the percentage 
of T lymphocytes. The serum of the remaining blood 
was used to detect the levels of cytokines after letting it 
stand and centrifugation.
Detection of T lymphocyte 
percentage by flow cytometry 
The anticoagulated whole blood (100 μL) was placed 
in the test tube for flow cytometry. The samples were 
mixed with 20 μL of Allophycocyanin (APC) Mouse 
anti-Rat CD3 (BD, NJ, USA), 20 μL of Fluorescein 
isothiocyanate (FITC) Mouse anti-Rat CD8a (BD), 
and 20 μL of Phycoerythrin (PE) Mouse anti-Rat CD4 
(BD). The samples (100 μL of anticoagulated whole 
blood) in the isotype control group were mixed with 
isotype control. All samples were analyzed to detect the 
percentage and ratio of CD4+ and CD8+T lymphocytes 
under a BD fluorescence-activated cell sorter (FACS) 
Verse II flow cytometer (BD).
Detection of the levels of interleukin-12 
and interferon-γ by enzyme-linked 
immunosorbent assay
The levels of serum interleukin (IL)-12 and 
interferon (IFN)-γ were detected using a microplate 
reader (Thermo Fisher Scientific Inc., MA, USA), IL-
12 enzyme-linked immunosorbent assay (ELISA) 
kit (Invitrogen, CA, USA), and IFN-γ ELISA kit 
(eBioscience, CA, USA). All the reagent samples and 
standards were prepared as instructed. The plate was 
washed, and the standard and sample were added, 
followed by antibody. Then the stop solution was added, 
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and the plate was read. (The detailed instructions on the 
relevant ELISA kit was followed). 
Test of carbon clearance capacity 
and phagocytic capacity
Diluted ink (0.1 mL/20 g body weight) was injected 
into the tail vein of the rats. Blood samples (30 μL) 
were obtained from the hearts after 5 (t1) and 15 (t2) 
min. The optical density (OD) values of the samples 
obtained at t1 (OD1) and t2 (OD2) were measured at 
650 nm wavelength. The rats were sacrificed by cervical 
dislocation, and the liver and spleen were weighed. The 
carbon clearance index K was calculated according 
to the formula K = (1 g ODl - l g OD2)/(t2 - t1). The 
phagocytic index a was calculated according to the 
formula a = body weight/(liver weight + spleen weight) 
× K1/3 (Singh, Yadav, Noolvi, 2012).
Detection of acid phosphatase activity in rat 
peritoneal macrophages by Gomori assay
Rats were injected intraperitoneally with 0.7 mL of 
6% sterile starch broth, and 0.1-0.2 mL of abdominal 
fluid was extracted after 3 days. The peritoneal fluid was 
dripped on a precooled slide and fixed with 10% neutral 
formalin. After adding acid phosphatase solution and 
1% ammonium sulfide successively, the cells were 
stained with Giemsa stain. The slides were examined 
under ordinary optical microscope to observe brown 
particles or plaques in macrophages (Anhe, Lima-
Oliveira, Azeredo-Oliveira, 2007).
Statistical analysis 
The experimental data were analyzed using 
the SPSS 19.0 software (SPSS Inc., IL, USA). T 
lymphocytes, cytokines test, carbon clearance capacity 
and phagocytic capacity test: At the same time point, 
the experimental and control groups were compared 
using two independent-sample t test, and t’ test was 
used to assess the heterogeneity of variance. The 
results were expressed as mean ± standard deviation 
(x ± s), and a P value < 0.05 was considered statistically 
significant. Acid phosphatase test: At the same time 
point, the experimental and control groups were 
compared using the rank-sum test. The results were 
expressed as mean rank, and a P value < 0.05 was 
considered statistically significant.
RESULTS AND DISCUSSION
Most people infected with Mtb develop a latent 
TB infection without any clinical symptoms that is not 
cleared by the immune system. Only a small number of 
patients develop an active TB infection. When various 
factors cause a decrease in the body’s immune function, 
the latent Mtb can be activated, allowing it to develop 
into active TB (Petruccioli et al., 2016; Riou et al., 
2016). Therefore, the inhibition and clearance of Mtb are 
closely related to immune function. This study selected 
normal healthy rats as subjects to avoid the effects of 
other factors on the immune system.
Comparison of CD4+T, CD8+T lymphocytes 
and CD4+/CD8+T lymphocyte cell ratio 
After feeding drug for 1 and 3 months, the percentage 
of CD4+T lymphocytes and the CD4+/CD8+T lymphocyte 
cell ratio was higher in the experimental group than in 
the control group, and the differences were statistically 
significant (P < 0.05). Moreover, after feeding drug for 
3 months followed by drug withdrawal for 1 month, 
no statistically significant difference was found in the 
CD4+T lymphocytes or CD4+/CD8+T lymphocyte cell 
ratio between the experimental and control groups (P 
> 0.05; Table I). No statistically significant difference 
was found in the CD8+T lymphocytes between the 
experimental and control groups at any time point 
(Figure 1, Table I).
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FIGURE 1 - CD4+T lymphocytes in (A) experimental group after drug feeding for 1 month, (B) control group after drug feeding 
for 1 month, (C) experimental group after drug feeding for 3 months, (D) control group after drug feeding for 3 months, (E) 
experimental group after drug feeding for 3 months followed by drug withdrawal for 1 month, (F) control group after drug 
feeding for 3 months followed by drug withdrawal for 1 month. CD8+T lymphocytes in (G) experimental group after drug 
feeding for 1 month, (H) control group after drug feeding for 1 month, (I) experimental group after drug feeding for 3 months, 
(J) control group after drug feeding for 3 months, (K) experimental group after drug feeding for 3 months followed by drug 
withdrawal for 1 month, (L) control group after drug feeding for 3 months followed by drug withdrawal for 1 month.
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TABLE I - Comparison of CD4+, CD8+T lymphocytes and CD4+/CD8+ ratio in the experimental and control groups at the three 
time points
Time point Experimental group(n=10) Control group (n=10) P-value
CD4+T lymphocytes (%)
Feeding drug for 1 month 48.332 ± 5.486 37.625 ± 4.192 0.000 a
Feeding drug for 3 months 42.169 ± 6.041 35.421 ± 7.882 0.045 a
Feeding drug for 3 months followed 
by drug withdrawal for 1 month
36.656 ± 5.639 32.642 ± 5.325 0.119 a
CD8+T lymphocytes (%)
Feeding drug for 1 month 11.243 ± 1.572 13.642 ± 3.292 0.058 a
Feeding drug for 3 months 12.280 ± 4.398 15.611 ± 5.557 0.154 a
Feeding drug for 3 months followed 
by drug withdrawal for 1 month
15.780 ± 6.048 15.963 ± 3.814 0.936 a
CD4+/CD8+ ratio
Feeding drug for 1 month 4.372 ± 0.780 2.880 ± 0.637 0.000 a
Feeding drug for 3 months 3.903 ± 1.579 2.552 ± 1.065 0.038 a
Feeding drug for 3 months followed 
by drug withdrawal for 1 month
2.604 ± 0.869 2.185 ± 0.723 0.256 a
a = Two independent-sample t test. P < 0.05 denoted statistical significant difference
Significance of T lymphocytes in the Mtb clearance
Mtb is an intracellular bacterium; CD4+ and 
CD8+T lymphocytes play important roles in the immune 
response against Mtb infection. Previous studies 
found that for patients with TB, the number of CD4+T 
lymphocytes decreased and the number of CD8+T 
lymphocytes increased. The CD4+/CD8+T lymphocyte 
cell ratio, which could be used to reflect the severity 
of TB, decreased or even inverted (Arroyo et al., 2016; 
Reiley et al., 2010; Scanga et al., 2000).
The effects of isoniazid on T lymphocytes in healthy 
male rats were investigated in this study. The results 
showed that isoniazid could increase the percentage of 
CD4+T lymphocytes and CD4+/CD8+T lymphocyte cell 
ratio in the peripheral blood of rats, and the percentages 
could be restored after isoniazid withdrawal. Moreover, 
isoniazid had no significant effect on CD8+T lymphocytes 
in the peripheral blood of rats.
Comparison of IL-12 and IFN-γ level
After feeding drug for 1, 3, and 3 months followed 
by drug withdrawal for 1 month, no statistically 
significant difference was found in the IL-12 and IFN-γ 
level between the experimental and control groups (P > 
0.05; Table II).
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TABLE II - Comparison of IL-12 and IFN-γ level in the experimental and control groups at the three time points
Time point Experimental group (n=10) Control group (n=10) P-value
IL-12 (pg/mL)
Feeding drug for 1 month 134.409 ± 25.128 131.752 ± 41.084 0.874 a
Feeding drug for 3 months 137.034 ± 65.937 96.211 ± 18.836 0.088 a
Feeding drug for 3 months followed 
by drug withdrawal for 1 month
113.241 ± 38.698 96.019 ± 20.463 0.234 a
IFN-γ (pg/mL)
Feeding drug for 1 month 121.552 ± 21.847 107.609 ± 34.765 0.297 a
Feeding drug for 3 months 118.444 ± 8.158 127.379 ± 24.003 0.289 a
Feeding drug for 3 months followed 
by drug withdrawal for 1 month
114.280 ± 18.796 105.517 ± 19.753 0.323 a
a = Two independent-sample t test. P < 0.05 denoted statistical significant difference
Significance of cytokines in the treatment of TB
Cytokines, such as IL-12 and IFN-γ, also play 
important roles in the immune response to Mtb infection 
(Chen et al., 2017; Mortaz et al., 2016). IL-12 can promote 
the proliferation and activation of T lymphocytes 
(Hamilton et al., 2016) and stimulate the production of 
IFN-γ. IL-12 can also activate macrophages and enhance 
the ability of anti-Mtb with IFN-γ (Thada et al., 2016). 
Recent studies showed that cytokine imbalance was a 
key factor in the occurrence and development of TB, and 
was closely related to TB prognosis (Anuradha et al., 
2016; Kreins et al., 2015).
The effects of isoniazid on the levels of IL-12 and 
IFN-γ in healthy male rats were investigated in this 
study. The results showed that the level of IL-12 in 
the serum of rats decreased as the rat’s age increased. 
However, the change in IL-12 level in the experimental 
group was not the same as in the control group. It did 
not decrease as the rat’s age increased, indicating that 
isoniazid might increase the level of IL-12 in the serum 
of rats, and this effect may become more significant 
as the administration time is extended. Also, the level 
of IL-12 could be restored after isoniazid withdrawal. 
These results were not statistically significant, possibly 
due to small sample size and short-term administration. 
Therefore, the effects of isoniazid on the level of IL-12 
in the serum of rats may be further examined in future 
studies by increasing the sample size and extending the 
administration time. The data presented here suggest 
that isoniazid may have no significant effect on IFN-γ 
level in the serum of rats.
Comparison of carbon clearance index, 
phagocytic index and acid phosphatase level
After 1 month of drug feeding, the carbon clearance 
index, phagocytic index, and acid phosphatase level in 
the experimental group was higher than in the control 
group, and the difference was statistically significant (P 
< 0.05). Moreover, after feeding drug for 3 and 3 months 
followed by drug withdrawal for 1 month, no statistically 
significant difference was found in the carbon clearance 
index, phagocytic index, or acid phosphatase level 
between the experimental and control groups (P > 0.05; 
Table III).
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TABLE III - Comparison of carbon clearance, phagocytic index and acid phosphatase level in the experimental and control 
groups at the three time points
Time point Experimental group (n=10) Control group (n=10) P-value
Carbon clearance index
Feeding drug for 1 month 0.017 ± 0.004 0.006 ± 0.001 0.000 a 
Feeding drug for 3 months 0.011 ± 0.001 0.012 ± 0.002 0.798 a
Feeding drug for 3 months followed 
by drug withdrawal for 1 month
0.024 ± 0.009 0.029 ± 0.009 0.248 a
Phagocytic index 
Feeding drug for 1 month 6.383 ± 0.602 4.637 ± 0.374 0.000 a
Feeding drug for 3 months 6.366 ± 0.578 6.377 ± 0.491 0.964 a
Feeding drug for 3 months followed 
by drug withdrawal for 1 month
8.391 ± 1.526 8.142 ± 0.989 0.671 a
Acid phosphatase level (Mean rank)
Feeding drug for 1 month 13.40 7.60 0.029 b
Feeding drug for 3 months 10.00 11.00 0.739 b
Feeding drug for 3 months followed 
by drug withdrawal for 1 month
11.25 9.75 0.579 b
a = Two independent-sample t test; b = Rank-sum test. P < 0.05 denoted statistical significant difference
Significance of macrophages in anti-tuberculosis
Macrophages play a role in innate immunity, 
and are critical cells in the immune response to Mtb 
infection. Activated macrophages can inhibit or even 
kill Mtb, which plays an important role in the control of 
Mtb infection (Auricchio et al., 2003). Carbon clearance 
capacity, phagocytic capacity, and acid phosphatase of 
macrophages can reflect their function. 
The effects of isoniazid on macrophage function in 
healthy male rats were explored in this study. Isoniazid 
enhanced the carbon clearance capacity, phagocytic 
capacity, and acid phosphatase activity of macrophages 
for a short period of time, but the long-term effects were 
not obvious. A possible explanation is that as innate 
immune cells, macrophages often respond swiftly to 
external stimuli then produce high levels of inflammatory 
mediators. On the other hand, the inflammatory activity 
of macrophages needs to be tightly regulated in order 
to prevent the inflammation-induced tissue damage. 
Many anti-inflammatory cytokines are also produced 
by activated macrophages to terminate their excessive 
activation. In contrast, the effects of adaptive immune 
cells, such as T lymphocytes, are generally persistent 
over a relatively long time period. Therefore, isoniazid 
treatment-induced enhancement of macrophage function 
may be antagonized by negative feed-back mechanisms, 
thus decreasing the long-term effect of isoniazid.
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CONCLUSION 
In summary, isoniazid could increase the percentage 
of CD4+T lymphocytes and CD4+/CD8+T lymphocyte 
cell ratio in peripheral blood and enhance macrophage 
function in healthy male rats. 
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